Work outsourced to Indian biotech and pharma companies is not yet significantly innovative.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Abstract:
      Many Indian biotech and pharma companies undertake contract research for companies based abroad. In order to quantify the inventorship associated with this outsourcing, we have studied the US patents assigned to non-Indian companies, with inventors based in India. Of the 4094 patents in all disciplines, only 20 were relevant, an insignificant number. If creative skills in the drug discovery process are not being honed, the prospects of original drug discovery in India are poor. This should be a matter of concern to the Indian government and others concerned with the price of future drugs. [ABSTRACT FROM AUTHOR]